FENC Stem Cell Isolation via FACsorting Antibody Selection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating stem cells from human tissues face challenges in achieving unlimited proliferation and differentiation capabilities similar to embryonic stem cells, as adult stem cells lack totipotency and handling embryonic cells for therapeutic and research purposes encounters ethical, legal, and technical difficulties.
Innovation Solution
A method for isolating a non-haematopoietic, mesenchymal stem subpopulation, FENC (Follicle-derived Embryonic Neural Crest stem cells), using FACsorting selection with specific antibodies, allowing for the expansion and differentiation of cells into all three germinal layers, enabling the creation of a totipotent/multipotent cell population that can be stored and used for therapeutic applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If adult stem cells are isolated from human tissues, then the cells can be collected for therapeutic use, but they lack unlimited proliferation ability and totipotency
Solution Approach 1:
The invention segments the stem cell isolation process into distinct steps: initial collection of follicular tissue, enzymatic digestion to release individual cells, and subsequent FACsorting based on specific surface markers. This segmentation allows for progressive purification and selection of cells with desired embryonic-like characteristics while maintaining their therapeutic potential
Solution Approach 2:
The invention changes the selection parameters from conventional adult stem cell markers to embryonic stem cell surface markers (SSEA-4, TRA-1-60, TRA-1-81). This parameter change enables the isolation of cells with embryonic-like proliferation and differentiation capabilities from adult human tissue, resolving the contradiction between therapeutic utility and cellular versatility
2Adaptability or versatility
If embryonic stem cells are used for therapeutic and research purposes, then unlimited proliferation and totipotency are achieved, but technical, ethical and legal difficulties arise
Solution Approach 1:
The invention uses FACsorting with specific surface markers as an intermediary technique to obtain embryonic-like stem cells from adult human tissue without requiring actual embryonic material. This intermediary approach provides a legal and ethical alternative that mimics embryonic stem cell properties while avoiding the associated ethical and legal complexities
Solution Approach 2:
The invention creates a copy of embryonic stem cell properties (surface markers, proliferation capacity, differentiation potential) in cells derived from adult human tissue. By copying the essential characteristics of embryonic stem cells without using embryos, the invention achieves therapeutic versatility while avoiding ethical and legal issues
3Quantity of substance
If conventional isolation methods are used, then stem cells can be collected, but the population is heterogeneous and lacks embryonic-like characteristics
Solution Approach 1:
The invention replaces conventional mechanical or non-specific selection methods with FACsorting, a flow cytometry-based technique that uses fluorescently labeled antibodies to specifically identify and isolate cells expressing embryonic stem cell surface markers. This substitution enables precise selection of homogeneous cell populations with desired characteristics while maintaining adequate cell yield
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a low-invasive, high-clonogenic stem cell isolation with minimal tissue sacrifice, enabling the use of embryonic-like stem cells for autologous therapeutic applications, including tissue engineering and cell therapy, with cells capable of differentiating into various tissue types without causing cancer, as demonstrated by successful transplantation and histological observations.
Implementation Method 1
FACsorting selection, after suitable staining with specific antibodies
Implementation Method 2
selection by cytofluorimetry of embryonic stem cells, through antigens detection such as SSEA-4, TRA 1-60, TRA 1-81
Data Source
AI summary
Methods for the isolation, expansion and storage of a population of stem cells belonging to human dental follicles, called FENC (Follicle-derived Embryonic Neural Crest stem cells,) including: a) Collection of the follicular sack in sterile conditions, digestion and primary culture growth and expansion; b) Optional amplification; c) FACsorting.